Global Cancer Tumor Profiling Market Overview:
Cancer tumour profiling is done to get genetic information regarding the tumour cells which offer useful insights and information regarding the disease. Cancer tumour profiling helps in the selection of suitable therapy for the treatment of cancer tumour. Cancer tumour profiling provides more precise and accurate information about the clinical outcomes of cancer. The technique plays an important role in the diagnosis of cancer at the molecular level. Cancer tumour profiling may increase the likelihood that a patient will benefit from cancer therapy. Some of the players profiled in the study are Siemens Healthcare GmbH (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Qiagen N.V. (Netherlands), Neogenomics Laboratories Inc. (United States), HTG Molecular Diagnostics Inc. (United States), Perthera, Inc. (United States), Strand Genomics (India), Contextual Genomics (Canada), QIAGEN N.V. (Germany) and Boreal Genomics (United States).
On the basis of geography, the market of Cancer Tumor Profiling has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Next-Generation Sequencing (NGS) will boost the Cancer Tumor Profiling market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End Use, the sub-segment i.e. Personalized Medicine will boost the Cancer Tumor Profiling market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Growth Drivers
- Increase in the Demand for Next Generation Sequencing Techniques in Cancer Tumour Profiling
- Rise in the Adoption of the Cancer Tumour Profiling Methods by Oncologists
- Growing Need for Point-Of-Care Diagnostic Tests
- Growing Utility of Biomarkers in Cancer Tumour Profiling
- Rise in Number of Cancer Cases
- High Capital Investments
- Lack of Skilled Professionals
- Availability of Funding for Cancer Research
- Increasing Demand for Personalized Medicine
- Targeting Cancer Stem Cells (CSCs) is Difficult
- Problems Associated with Cancer Tumour Diagnosis
Key Market Developments:
March 08, 2019: QIAGEN N.V. and Tecan Group AG, a global leader in laboratory automation and liquid handling technology, announced a collaboration to improve the processing of QIAGENís QuantiFERON-TB Gold Plus (QFT-Plus) diagnostic test through the utilization of Tecanís Fluent Laboratory Automation.
March 11, 2019: NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announce availability of the Ventana PD-L1 (SP142) Assay for tumor tissue from patients with the triple negative subtype of breast cancer.
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to avail competitive advantage through combined collaborations.
Companies Offering Platforms for Cancer Tumour Diagnosis, Healthcare Industry, Research Institutes and Government Bodies
Major Objectives Focused through this Study
To define, describe, and forecast the Global Cancer Tumor Profiling market on the basis of product [Breast Cancer, Lung Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer and Others [Melanoma, Colorectal, Bladder, Leukemia]] , application [Clinical, Screening and Research], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Cancer Tumor Profiling market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Cancer Tumor Profiling industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Helomics Corp (United States), Oxford Gene Technology Ltd (United Kingdom), GenomeDx (Canada), Foundation Medicine Inc. (United States) and NanoString Technologies Inc. (United States).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Cancer Tumor Profiling market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.